Clinical Trials Directory

Trials / Completed

CompletedNCT02030704

CCTA-based Coronary Plaque Characterization and High-sensitive Troponin T for the Prediction of Cardiovascular Outcomes

Comprehensive 'Bio-Imaging' Using Quantitative Coronary Plaque Composition Assessment and the High-sensitive Troponin T for the Prediction of Cardiac Outcomes.

Status
Completed
Phase
Study type
Observational
Enrollment
300 (actual)
Sponsor
University Hospital Heidelberg · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

To determine the ability of semi-automated plaque assessment in cardiac computed tomography angiography (CCTA) and high sensitive troponin T (hsTnT) for the risk stratification of patients at intermediate risk for coronary artery disease (CAD).

Conditions

Timeline

Start date
2008-02-01
Primary completion
2018-09-01
Completion
2018-09-01
First posted
2014-01-08
Last updated
2018-09-11

Locations

2 sites across 2 countries: Germany, Hungary

Source: ClinicalTrials.gov record NCT02030704. Inclusion in this directory is not an endorsement.

CCTA-based Coronary Plaque Characterization and High-sensitive Troponin T for the Prediction of Cardiovascular Outcomes (NCT02030704) · Clinical Trials Directory